Fresh Start with Dr. David - Season 2 - Episode 28 - Diabetes Drugs, COVID19 (COVID Brain Fog & Clotting Proteins), The Season of Fall, Healthcare Insurance, & The See Saw Principle

Fresh Start with Dr. David - Season 2 - Episode 28 -Diabetes Drugs, COVID19 (COVID Brain Fog & Clotting Proteins), The Season of Fall, Healthcare Insurance, & The See Saw Principle (Equalizer Principle) (Proportionality Principle) (Plastic Surgery Principle)

This Podcast Episode is all about Diabetes Drugs, COVID & Other Viruses (Study on COVID Brain Fog and Clotting Proteins), The Energy & Power of Fall, and Healthcare Insurance (FSAs vs. HSAs [Investment Rollover], PPOs vs. HMOs, etc.), Correlations between Diabetes Drugs and other things (SSRIs Depression, Stimulants for ADHD, Marijuana for Anxiety, Cigarettes/Vaping [Nicotine] for Anxiety/Boredom, EtOH for Anxiety/Relaxation).

I also discuss The See Saw Principle (Equalizer Principle) (Proportionality Principle) (Plastic Surgery Principle).

You don't want to miss this episode where I chat about Jillian Michaels, one of Americans Top Trainers, and what she and others are sharing about the dangers of using Diabetes Drugs just to lose weight.

 

Ozempic injections, which contain the active ingredient Semaglutide, function as a GLP-1 receptor agonist. GLP-1 receptor agonists mimic the actions of the metabolic hormone glucagon-like peptide-1 (GLP-1). By stimulating insulin secretion, GLP-1 receptor agonists can help lower blood sugar levels, making them beneficial for individuals with diabetes.

One of the effects of GLP-1 receptor agonists like Semaglutide is the slowing of gastric emptying. This means that food stays in the stomach for a longer period, leading to increased satiety and a reduced desire to eat. This aspect of Ozempic injections can be helpful in weight management and promoting weight loss. 

However, it is important to acknowledge the existing controversy surrounding GLP-1-based therapy, including Ozempic injections. Studies and research have examined the potential risks associated with GLP-1 receptor agonists, such as the development of malignant diseases like pancreatic carcinoma and thyroid cancer. 

 

The most common include nausea, diarrhea, vomiting, stomach pain and constipation, according to Novo Nordisk, the company that makes both Ozempic and Wegovy. But patients may also experience serious side effects such as pancreatitis, gallbladder problems and kidney failure, it warns.

Ozempic® may cause serious side effects, including:

Possible thyroid tumors, including cancer. Tell your health care provider if you get a lump or swelling in your neck, hoarseness, trouble swallowing, or shortness of breath. These may be symptoms of thyroid cancer. In studies with rodents, Ozempic® and medicines that work like Ozempic® caused thyroid tumors, including thyroid cancer. It is not known if Ozempic® will cause thyroid tumors or a type of thyroid cancer called medullary thyroid carcinoma (MTC) in people.  Do not use Ozempic® if you or any of your family have ever had MTC, or if you have an endocrine

‘Ozempic Butt’

'Ozempic Face'

1. Nausea and vomiting Nausea is the most common semaglutide side effect. Up to 20% of people taking it for Type 2 diabetes reported nausea in clinical trials. Nausea is even more common if you’re taking the higher-dose version for weight loss. Vomiting tends to be less common than nausea.

You’re more likely to experience these side effects with higher doses of semaglutide. That’s why your healthcare provider will raise your dose slowly over a few weeks to minimize these effects. For most people, these side effects should improve over time as your body gets used to the medication.

Eating smaller meals, avoiding high-fat foods, and remaining upright after you eat can also help manage potential nausea and vomiting from semaglutide. But if these side effects are accompanied by severe stomach pain that may or may not spread to your back, get medical attention right away. This could be a sign of pancreatitis, a rare but